137 related articles for article (PubMed ID: 29633258)
1. A comparative study on pathological features of transgenic rat lines expressing either three or four repeat misfolded tau.
Valachova B; Brezovakova V; Bugos O; Jadhav S; Smolek T; Novak P; Zilka N
J Comp Neurol; 2018 Aug; 526(11):1777-1789. PubMed ID: 29633258
[TBL] [Abstract][Full Text] [Related]
2. Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load.
Koson P; Zilka N; Kovac A; Kovacech B; Korenova M; Filipcik P; Novak M
Eur J Neurosci; 2008 Jul; 28(2):239-46. PubMed ID: 18702695
[TBL] [Abstract][Full Text] [Related]
3. Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer's disease.
Stozicka Z; Zilka N; Novak P; Kovacech B; Bugos O; Novak M
J Neuroinflammation; 2010 Oct; 7():64. PubMed ID: 20937161
[TBL] [Abstract][Full Text] [Related]
4. Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies.
Irwin DJ; Cohen TJ; Grossman M; Arnold SE; Xie SX; Lee VM; Trojanowski JQ
Brain; 2012 Mar; 135(Pt 3):807-18. PubMed ID: 22366796
[TBL] [Abstract][Full Text] [Related]
5. Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies.
de Silva R; Lashley T; Gibb G; Hanger D; Hope A; Reid A; Bandopadhyay R; Utton M; Strand C; Jowett T; Khan N; Anderton B; Wood N; Holton J; Revesz T; Lees A
Neuropathol Appl Neurobiol; 2003 Jun; 29(3):288-302. PubMed ID: 12787326
[TBL] [Abstract][Full Text] [Related]
6. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
7. Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration.
Higuchi M; Ishihara T; Zhang B; Hong M; Andreadis A; Trojanowski J; Lee VM
Neuron; 2002 Aug; 35(3):433-46. PubMed ID: 12165467
[TBL] [Abstract][Full Text] [Related]
8. High copy wildtype human 1N4R tau expression promotes early pathological tauopathy accompanied by cognitive deficits without progressive neurofibrillary degeneration.
Wheeler JM; McMillan PJ; Hawk M; Iba M; Robinson L; Xu GJ; Dombroski BA; Jeong D; Dichter MA; Juul H; Loomis E; Raskind M; Leverenz JB; Trojanowski JQ; Lee VM; Schellenberg GD; Kraemer BC
Acta Neuropathol Commun; 2015 Jun; 3():33. PubMed ID: 26041339
[TBL] [Abstract][Full Text] [Related]
9. Human Truncated Tau Induces Mature Neurofibrillary Pathology in a Mouse Model of Human Tauopathy.
Zimova I; Brezovakova V; Hromadka T; Weisova P; Cubinkova V; Valachova B; Filipcik P; Jadhav S; Smolek T; Novak M; Zilka N
J Alzheimers Dis; 2016 Sep; 54(2):831-43. PubMed ID: 27567836
[TBL] [Abstract][Full Text] [Related]
10. Of rodents and men: the mysterious interneuronal pilgrimage of misfolded protein tau in Alzheimer’s disease.
Levarska L; Zilka N; Jadhav S; Neradil P; Novak M
J Alzheimers Dis; 2013; 37(3):569-77. PubMed ID: 23948940
[TBL] [Abstract][Full Text] [Related]
11. First-in-Rat Study of Human Alzheimer's Disease Tau Propagation.
Smolek T; Jadhav S; Brezovakova V; Cubinkova V; Valachova B; Novak P; Zilka N
Mol Neurobiol; 2019 Jan; 56(1):621-631. PubMed ID: 29770957
[TBL] [Abstract][Full Text] [Related]
12. Trafficking of immune cells across the blood-brain barrier is modulated by neurofibrillary pathology in tauopathies.
Majerova P; Michalicova A; Cente M; Hanes J; Vegh J; Kittel A; Kosikova N; Cigankova V; Mihaljevic S; Jadhav S; Kovac A
PLoS One; 2019; 14(5):e0217216. PubMed ID: 31120951
[TBL] [Abstract][Full Text] [Related]
13. Templated misfolding of Tau by prion-like seeding along neuronal connections impairs neuronal network function and associated behavioral outcomes in Tau transgenic mice.
Stancu IC; Vasconcelos B; Ris L; Wang P; Villers A; Peeraer E; Buist A; Terwel D; Baatsen P; Oyelami T; Pierrot N; Casteels C; Bormans G; Kienlen-Campard P; Octave JN; Moechars D; Dewachter I
Acta Neuropathol; 2015 Jun; 129(6):875-94. PubMed ID: 25862635
[TBL] [Abstract][Full Text] [Related]
14. Intracellular degradation of misfolded tau protein induced by geldanamycin is associated with activation of proteasome.
Opattova A; Filipcik P; Cente M; Novak M
J Alzheimers Dis; 2013; 33(2):339-48. PubMed ID: 22936006
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulation of memory-impairing protein tau in Alzheimer's disease.
Zilka N; Stozicka Z; Cente M; Kazmerova Z; Kovacech B; Novak M
Neurodegener Dis; 2012; 10(1-4):242-5. PubMed ID: 22433908
[TBL] [Abstract][Full Text] [Related]
16. Different tau species lead to heterogeneous tau pathology propagation and misfolding.
Dujardin S; Bégard S; Caillierez R; Lachaud C; Carrier S; Lieger S; Gonzalez JA; Deramecourt V; Déglon N; Maurage CA; Frosch MP; Hyman BT; Colin M; Buée L
Acta Neuropathol Commun; 2018 Nov; 6(1):132. PubMed ID: 30497516
[TBL] [Abstract][Full Text] [Related]
17. Changes in lipid metabolism track with the progression of neurofibrillary pathology in tauopathies.
Olešová D; Dobešová D; Majerová P; Brumarová R; Kvasnička A; Kouřil Š; Stevens E; Hanes J; Fialová Ľ; Michalicová A; Piešťanský J; Šinský J; Kaňovský P; Friedecký D; Kováč A
J Neuroinflammation; 2024 Mar; 21(1):78. PubMed ID: 38539208
[TBL] [Abstract][Full Text] [Related]
18. Tau protein is cross-linked by transglutaminase in P301L tau transgenic mice.
Halverson RA; Lewis J; Frausto S; Hutton M; Muma NA
J Neurosci; 2005 Feb; 25(5):1226-33. PubMed ID: 15689560
[TBL] [Abstract][Full Text] [Related]
19. Accelerated extinction of conditioned taste aversion in P301L tau transgenic mice.
Pennanen L; Welzl H; D'Adamo P; Nitsch RM; Götz J
Neurobiol Dis; 2004 Apr; 15(3):500-9. PubMed ID: 15056457
[TBL] [Abstract][Full Text] [Related]
20. First transgenic rat model developing progressive cortical neurofibrillary tangles.
Filipcik P; Zilka N; Bugos O; Kucerak J; Koson P; Novak P; Novak M
Neurobiol Aging; 2012 Jul; 33(7):1448-56. PubMed ID: 21196063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
